Medicine and Dentistry
Arteriosclerosis Obliterans
100%
Vascular Surgery
94%
Abdominal Aortic Aneurysm
64%
Screening
45%
Cardiovascular System
43%
Prevalence
36%
Amputation
32%
ACE Inhibitor
24%
Cohort Analysis
23%
Cardiovascular Disease
21%
Toe
19%
Myocardial Infarction
19%
Revascularization
18%
All Cause Mortality
18%
Beta Adrenergic Receptor Blocking Agent
16%
Diabetes Mellitus
16%
Hypolipidemic Agent
15%
Ankle Brachial Index
15%
Blood Pressure
15%
Apoplexy
15%
Population
14%
Limb
14%
Surgery
14%
Cost-Effectiveness Analysis
13%
Antiplatelet
13%
Angiotensin Receptor Antagonist
13%
Hemoglobin A1c
11%
Surgeon
10%
Intermittent Claudication
10%
Popliteal Artery
9%
Knee Dislocation
9%
Acetylsalicylic Acid
9%
Plethysmography
9%
Intramedullary Nailing
9%
Erysipelas
9%
External Fixation
9%
C Reactive Protein
9%
Colles Fracture
9%
Blood Flow
9%
Cardiovascular Condition
9%
Mass Screening
9%
Distal Radius Fracture
9%
Roxithromycin
9%
Pulse Rate
9%
Renin
9%
Diabetes
9%
Radial Nerve
9%
Telemedicine
9%
Angiotensin
9%
Postmenopause
9%
Nursing and Health Professions
Peripheral Occlusive Artery Disease
26%
Abdominal Aortic Aneurysm
19%
Cyclorphan
19%
Ankle Brachial Index
15%
Amputation
14%
Health Care Personnel
13%
Screening
13%
Cardiovascular Disease
11%
Diabetes Mellitus
11%
Vascular Surgery
11%
Propensity Score
11%
Telemedicine
9%
Pulse Rate
9%
Blood Vessel Shunt
9%
Angiotensin
9%
Roxithromycin
9%
Blood Flow
9%
Hemoglobin A1c
9%
Beta Adrenergic Receptor Blocking Agent
9%
Blood Patch
9%
Hard-To-Heal
9%
Intermittent Claudication
9%
Clinical Outcome
9%
Palpation
9%
Renin
9%
Biological Marker
9%
Prophylaxis
9%
Evaluation Study
9%
Pill
9%
Drug Therapy
9%
Revascularization
6%
Confidence Interval
6%
Care Pathway
6%
Medication Compliance
5%
Heart Infarction
5%
Angiotensin Receptor Antagonist
5%
Dipeptidyl Carboxypeptidase Inhibitor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Aortic Aneurysm
51%
Peripheral Occlusive Artery Disease
42%
All Cause Mortality
19%
Antilipemic Agent
18%
Beta Adrenergic Receptor Blocking Agent
17%
Heart Infarction
17%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Angiotensin Receptor Antagonist
14%
Cohort Study
13%
Prevalence
11%
Antiplatelet
11%
Cardiovascular Disease
9%
Small Clinical Trial
9%
Roxithromycin
9%
Acute Aortic Syndrome
9%
Angiotensin
9%
Acetylsalicylic Acid
9%
Intermittent Claudication
9%
Renin
9%
Antihypertensive Therapy
9%
Aortic Aneurysm
9%
Long Term Survival
6%
Infection
6%
Combination Therapy
6%
Adverse Event
5%